Avalyn Pharma Inc. · NASDAQ:AVLN
FMR LLC converted 2,284,535 Avalyn Pharma Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, FMR LLC (10% owner, See Remark 1) converted 2,284,535 Avalyn Pharma Inc. shares, leaving 2,284,535 shares. Filed May 5, 2026 (Form 4).
- Converted
- 2,284,535 shares
- Holding after
- 2,284,535 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner, See Remark 1
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Conversion | 727,585 | 727,585 | Indirect | |
| May 1, 2026 | Common Stock | Conversion | 80,291 | 807,876 | Indirect | |
| May 1, 2026 | Common Stock | Conversion | 872,868 | 1,680,744 | Indirect | |
| May 1, 2026 | Common Stock | Conversion | 225,843 | 1,906,587 | Indirect | |
| May 1, 2026 | Common Stock | Conversion | 377,948 | 2,284,535 | Indirect |
Source
Related
- Avalyn Pharma Inc.
- FMR LLC
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026